We demonstrate for the first time the biological role of lncRNASNHG4 in COPD, where it ameliorates CSE-induced apoptosis, inflammation, oxidative stress, and airway remodeling by competitively binding miR-409-3p to modulate FHL1 expression. Here, FHL1 is linked to chronic obstructive pulmonary disease.